Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$25.61

0.36 (1.43%)

06:28
07/31/17
07/31
06:28
07/31/17
06:28

Biohaven initiates second pivotal Phase 3 clinical trial of rimegepant

Biohaven Pharmaceutical announced that it has commenced enrollment in the second of its two registrational Phase 3 clinical trials to evaluate the safety and efficacy of its orally-dosed rimegepant for the acute treatment of migraine. Biohaven is conducting two double-blinded, placebo-controlled Phase 3 clinical trials to evaluate the efficacy and safety of 75 mg of rimegepant, Biohaven's innovative, orally-dosed small molecule CGRP receptor antagonist, for the acute treatment of migraine. The co-primary endpoints of the studies are freedom from pain at two hours post-dosing and a demonstrated effect on the patient's most bothersome symptom at two hours post-dosing. Patients in the Phase 3 clinical trials will be eligible to participate in a long-term safety study.

BHVN Biohaven Pharmaceutical
$25.61

0.36 (1.43%)

05/31/17
MSCO
05/31/17
INITIATION
Target $28
MSCO
Overweight
Biohaven Pharmaceutical initiated with an Overweight at Morgan Stanley
Morgan Stanley initiated Biohaven Pharmaceutical with an Overweight and a $28 price target.
05/30/17
05/30/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ovid Therapeutics (OVID) was initiated with a Buy at Citi and an Outperform at William Blair, JMP Securities, and Cowen. 2. Antero Midstream Partners (AM) was resumed with an Overweight at Morgan Stanley, initiated with an Outperform at Credit Suisse, and reinstated with an Overweight at Barclays. 3. Antero Midstream GP (AMGP) was initiated with an Overweight at Morgan Stanley, JPMorgan, and Barclays, an Outperform at Baird and Credit Suisse, a Market Perform at Wells Fargo, a Strong Buy at Raymond James, a Buy at Goldman Sachs, Ladenburg, and DA Davidson, as well as a Hold at Stifel. 4. Biohaven Pharmaceutical (BHVN) was initiated with an Outperform at William Blair, an Overweight at Piper Jaffray and Barclays, as well as a Buy at Needham. 5. Pieris Pharmaceuticals (PIRS) initiated with a Buy at Rodman & Renshaw. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/30/17
WBLR
05/30/17
INITIATION
WBLR
Outperform
Biohaven Pharmaceutical initiated with an Outperform at William Blair
William Blair analyst Tim Lugo started Biohaven Pharmaceutical with an Outperform rating and sees a fair value estimate of $46 per share. Biohaven can "grow quickly" and become a "clear" takeover target in 2018, Lugo tells investors in a research note.
05/30/17
NEED
05/30/17
INITIATION
Target $30
NEED
Buy
Biohaven Pharmaceutical initiated with a Buy at Needham
Needham analyst Alan Carr started Biohaven Pharmaceutical with a Buy rating and $30 price target.

TODAY'S FREE FLY STORIES

USLV

VelocityShares 3x Long Silver ETN

$12.17

0.39 (3.31%)

06:21
11/24/17
11/24
06:21
11/24/17
06:21
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$82.33

-0.23 (-0.28%)

06:20
11/24/17
11/24
06:20
11/24/17
06:20
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBB

iShares Nasdaq Biotechnology Index

$312.52

1.81 (0.58%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$5.34

-0.09 (-1.66%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$32.05

-0.15 (-0.47%)

, NKTR

Nektar

$49.75

-0.23 (-0.46%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Hot Stocks
Bayer announces INHALE Phase III clinical study did not meet primary endpoint »

Bayer (BAYRY) announced…

BAYRY

Bayer

$32.05

-0.15 (-0.47%)

NKTR

Nektar

$49.75

-0.23 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$26.02

0.02 (0.08%)

06:19
11/24/17
11/24
06:19
11/24/17
06:19
Technical Analysis
MSCI Hong Kong Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$32.82

-0.22 (-0.67%)

06:18
11/24/17
11/24
06:18
11/24/17
06:18
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCMGY

Newcrest Mining

$18.13

0.2 (1.12%)

06:18
11/24/17
11/24
06:18
11/24/17
06:18
Downgrade
Newcrest Mining rating change  »

Newcrest Mining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$76.06

-0.16 (-0.21%)

06:16
11/24/17
11/24
06:16
11/24/17
06:16
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$47.81

0.12 (0.25%)

06:16
11/24/17
11/24
06:16
11/24/17
06:16
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$51.43

0.4 (0.78%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPYYY

Centrica

$8.66

0.18 (2.12%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Upgrade
Centrica rating change  »

Centrica upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$50.43

0.39 (0.78%)

, CBS

CBS

$56.24

-0.5 (-0.88%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Hot Stocks
Dish reaches multi-year carriage agreement with CBS, terms not disclosed »

DISH Network (DISH) has…

DISH

Dish

$50.43

0.39 (0.78%)

CBS

CBS

$56.24

-0.5 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$24.24

-0.19 (-0.78%)

06:14
11/24/17
11/24
06:14
11/24/17
06:14
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$22.23

0.1881 (0.85%)

06:13
11/24/17
11/24
06:13
11/24/17
06:13
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$13.48

0.15 (1.13%)

06:10
11/24/17
11/24
06:10
11/24/17
06:10
Periodicals
Teva to slash up to 25% of Israeli workforce, Bloomberg reports »

Teva intends to cut as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BASFY

BASF

$27.39

-0.13 (-0.47%)

04:55
11/24/17
11/24
04:55
11/24/17
04:55
Conference/Events
BASF management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Nov

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

November PMI Composite…

RBS

RBS

$7.30

-0.04 (-0.54%)

04:55
11/24/17
11/24
04:55
11/24/17
04:55
Conference/Events
RBS management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Nov

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
Breaking General news story  »

Week of 11/22 Fed Balance…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
Breaking General news story  »

Week of 11/24…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
Breaking General news story  »

Week of 11/13 Money…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
Conference/Events
RBC Capital to hold field trip »

European Utilities Field…

04:55
11/24/17
11/24
04:55
11/24/17
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

November PMI Composite…

02:45
11/24/17
11/24
02:45
11/24/17
02:45
General news
FX Update: The dollar has managed to find a footing »

FX Update: The dollar…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.